Sensus Healthcare: Q3 Results Showed That The Stock Is Undervalued

Sensus Healthcare (NASDAQ: SRTS ) is a company that develops equipment to treat skin problems, including non-melanoma cancer. I had previously covered the company in which I commented that the initiatives to generate recurring revenue wereMy name is María Fernanda and I am currently studying an MBA. My inspiration investors are Warren Buffett, Peter Lynch and Terry Smith, so I look for quality companies at a reasonable valuation. I believe that, in the long term, fundamentals are what drive the share price, ...